Stem Cell Therapy for Alzheimer's Disease

Alzheimer

Stem cell therapy offers a new approach to Alzheimer’s by targeting brain cell loss, not just symptoms. Learn how this emerging treatment could slow progression and restore cognitive function.

Stem cell therapy is an experimental treatment that uses the body’s own regenerative cells to repair or replace damaged tissue, including brain cells lost to Alzheimer’s disease.

Alzheimer’s affects over 55 million people worldwide and remains the most common cause of dementia. Despite decades of research, there’s still no cure. Current drugs only manage symptoms. This is why stem cell therapy is generating interest: it aims to target the disease at its root.

We explain what Alzheimer’s is, outlines current symptoms and treatments, and explores how stem cells are being tested in clinical trials. You’ll learn what types of stem cells are used, their potential benefits, safety concerns, and whether this therapy might offer new hope for patients.

What is Alzheimer's disease?

Alzheimer’s disease is a progressive brain disorder that slowly destroys memory and thinking skills. It eventually affects the ability to carry out simple tasks.

It’s the most common cause of dementia, a general term for memory loss and cognitive decline that interferes with daily life. Alzheimer’s typically starts after age 65, but early-onset cases can appear as early as a person’s 40s or 50s.

What are the symptoms of Alzheimer's disease?

Alzheimer’s symptoms develop gradually and worsen over time. Early signs may be subtle, but they typically become more severe and disabling in later stages.

Common symptoms include:

  • Memory loss: Especially forgetting recently learned information, important dates, or events.
  • Language problems: Difficulty finding the right words, following conversations, or repeating oneself often.
  • Disorientation: Confusion about time, place, or familiar routes.
  • Poor judgment: Trouble making decisions, managing money, or recognizing danger.
  • Difficulty with tasks: Struggling to complete familiar activities like cooking, using appliances, or organizing a schedule.
  • Changes in mood and behavior: Increased anxiety, depression, irritability, or withdrawal from social activities.
  • Misplacing items: Putting things in unusual places and being unable to retrace steps to find them.
  • Loss of initiative: Reduced interest in work, hobbies, or interacting with others.

As the disease progresses, individuals may need full-time care. Late-stage Alzheimer’s often involves severe memory loss, difficulty speaking or walking, and total dependence on others.

What are the causes of Alzheimer?

The exact cause of Alzheimer’s disease is not fully understood. However, researchers believe it develops from a combination of genetic, environmental, and lifestyle factors that affect the brain over time.

Key contributing factors include:

  • Abnormal protein buildup: Alzheimer’s is marked by two types of abnormal proteins in the brain:
    • Amyloid plaques: Clumps of beta-amyloid protein that build up between nerve cells.
    • Neurofibrillary tangles: Twisted strands of tau protein that form inside brain cells.
      These proteins disrupt communication between neurons and lead to cell death.
  • Genetics: Having a family history increases risk. The APOE-e4 gene variant is the strongest known genetic risk factor for late-onset Alzheimer’s. Rare inherited forms, such as early-onset familial Alzheimer’s, are caused by specific gene mutations.
  • Age: The biggest risk factor. Risk doubles approximately every five years after age 65.
  • Inflammation and vascular damage: Chronic brain inflammation and reduced blood flow may accelerate disease progression.
  • Lifestyle factors: Poor cardiovascular health, lack of exercise, smoking, and uncontrolled diabetes can increase risk.

Is there a treatment for Alzheimer's?

There is currently no cure for Alzheimer’s disease. However, treatments are available to help manage symptoms and slow the progression in some individuals.

Approved Medications

Two main types of drugs are used:

  • Cholinesterase inhibitors (e.g., donepezil, rivastigmine, galantamine):
    These improve communication between nerve cells by boosting acetylcholine levels, a key neurotransmitter. They are used in mild to moderate stages.
  • NMDA receptor antagonist (e.g., memantine):
    This regulates glutamate, another brain chemical involved in learning and memory. It’s often prescribed in moderate to severe stages.

In 2021, the FDA approved aducanumab, the first drug targeting beta-amyloid plaques. More recently, lecanemab and donanemab have shown promise in slowing cognitive decline by targeting amyloid buildup. These therapies are still being evaluated for long-term effects and are not widely accessible in all countries.

Supportive Therapies

  • Behavioral interventions: Tailored routines, environmental changes, and caregiver education can help manage agitation, confusion, and sleep problems.
  • Cognitive stimulation and physical activity: These may help maintain function and improve quality of life.

Ongoing Research

Many clinical trials are investigating new drugs that target tau protein, inflammation, and other disease mechanisms. Stem cell therapy is also under study as a potential approach, which we will explore further in this article.

While current treatments can’t stop the disease, they offer relief and may prolong independence in the early stages.

What is stem cell therapy for Alzheimer's disease?

Stem cell therapy is an emerging approach that aims to repair or replace damaged brain cells in Alzheimer’s disease. Unlike traditional drugs that manage symptoms, stem cell treatments target the underlying brain cell loss that defines the disease.

How It Works

Stem cells are undifferentiated cells that can develop into many types of specialized cells, including neurons. In Alzheimer’s research, scientists aim to:

  • Replace lost neurons: By introducing stem cells that can develop into healthy brain cells.
  • Reduce inflammation: Some stem cells release factors that protect existing neurons and reduce brain inflammation.
  • Restore function: Rebuilding neural networks could improve memory, cognition, and daily functioning.

Types of Stem Cells Studied

Several types of stem cells are under investigation for Alzheimer’s:

  • Embryonic stem cells (ESCs): These can become any cell type but raise ethical concerns and risk of tumor formation.
  • Induced pluripotent stem cells (iPSCs): Adult cells reprogrammed to act like ESCs. They are patient-specific and avoid immune rejection.
  • Mesenchymal stem cells (MSCs): Found in bone marrow or fat tissue. They are easier to harvest and have anti-inflammatory effects.

While promising, stem cell therapy for Alzheimer’s is still in experimental stages. Most evidence comes from animal studies or early-phase human trials. No stem cell treatment has yet been approved for Alzheimer’s by regulatory agencies.

Can Alzheimer's disease be cured with stem cell therapies?

Currently, we cannot say that stem cell therapies cure Alzheimer's disease. However, it shows potential as a future treatment that could slow or partially reverse disease progression.

What the Research Shows

  • Animal studies have demonstrated that stem cells can improve memory and reduce brain inflammation in mice with Alzheimer-like symptoms.
  • Early-phase human trials suggest that stem cell therapy is generally safe and may improve cognitive function in some patients.
  • However, results are inconsistent. Most studies are small, and there is not enough long-term data to confirm effectiveness or safety.

Further Scientific Readings:

Key Challenges

Several barriers must be addressed before stem cell therapy can become a viable treatment:

  • Targeting and integration: Implanted stem cells must survive, migrate to the right brain regions, and form functional connections.
  • Risk of complications: There is a possibility of immune reactions, abnormal growths, or tumor formation.
  • Standardization and regulation: Protocols for cell sourcing, preparation, and administration vary widely. This complicates comparisons across studies.

Stem cell therapy is an exciting research frontier, but it remains experimental. No current stem cell treatment can stop Alzheimer’s totally. Ongoing clinical trials will determine whether these therapies can become part of mainstream care in the future.

Can stem cell research help with Alzheimer’s?

Yes, stem cell research holds significant promise for advancing the treatment of Alzheimer’s disease. Although it has not yet led to a cure, it is expanding our understanding of the disease and enabling new therapeutic approaches.

Further Reading: How close is the stem cell cure to the Alzheimer's disease

Alzheimer’s Disease Stem Cell Treatment Clinical Trials

Stem cell therapy is one of the most closely watched experimental treatments for Alzheimer’s disease. While still in the early stages of development, several clinical trials have begun to explore whether stem cells can slow or reverse the disease’s progression by reducing inflammation, replacing damaged neurons, and supporting brain function.

These trials primarily use mesenchymal stem cells (MSCs), which are known for their regenerative and anti-inflammatory properties.

A leading example is the Laromestrocel (Lomecel-B) Phase 2a trial, which tested donor-derived bone marrow MSCs in 49 patients with mild Alzheimer’s. Results showed that the therapy was safe and well-tolerated, with treated participants experiencing slower brain shrinkage and better-preserved hippocampal volume compared to the placebo group. Some cognitive measures also showed signs of stabilization.

Another ongoing study at UTHealth Houston uses autologous MSCs derived from patients’ own fat tissue. This trial targets individuals who have Alzheimer’s biomarkers but no symptoms. It aims to prevent or delay symptom onset by reducing neuroinflammation early in the disease process. The study is in its early stages, focusing primarily on safety and inflammatory markers seen on PET scans.

Other trials registered under ClinicalTrials.gov are testing various MSC sources—including umbilical cord and adipose tissue—in patients with mild to moderate dementia. While these studies are still small, preliminary results are consistent: stem cell infusions appear safe and may offer modest cognitive benefits.

A recent systematic review covering 21 trials confirmed these findings, reporting no major adverse events and early signals of efficacy, such as improved memory and reduced inflammation.

Overall, these clinical trials represent critical steps toward developing stem cell-based therapies for Alzheimer’s. While larger and longer-term studies are needed to confirm benefits, early results suggest a promising future for this approach.

✅ What This Means

  • Safety: All tested MSC treatments have shown no major adverse effects in early human trials.
  • Efficacy signals: Evidence points to slowed brain atrophy and possible cognitive stabilization.
  • Next steps: Larger Phase 2b/3 trials are going on for definitive proof. Measuring long-term cognitive impact remains the largest evidence gap.

Why Use Stem Cells to Treat Alzheimer’s Disease?

Stem cells offer a unique therapeutic approach for Alzheimer’s because they can target the root causes of the disease—neuronal loss, inflammation, and disrupted brain function—rather than just managing symptoms.

Key Reasons for Their Use

  • Neuronal regeneration:
    Alzheimer’s leads to widespread death of brain cells, especially in areas critical for memory and cognition. Stem cells can potentially replace these lost neurons or support the survival of remaining ones.
  • Anti-inflammatory effects:
    Chronic brain inflammation is a core feature of Alzheimer’s. Certain stem cells, particularly mesenchymal stem cells (MSCs), release signaling molecules that reduce inflammation and protect neurons from further damage.
  • Neuroprotection and repair:
    Stem cells may secrete growth factors that support brain repair, stimulate the formation of new blood vessels, and promote connections between neurons (synapses).
  • Versatility:
    Different types of stem cells—like induced pluripotent stem cells (iPSCs) and neural stem cells—can be tailored for specific therapeutic goals, such as restoring damaged brain circuits or modeling the disease for drug testing.
  • Personalized medicine potential:
    iPSCs derived from a patient’s own cells can reduce the risk of immune rejection and allow for customized treatments.

FREQUENTLY ASKED QUESTIONS

What stem cells are used for alzheimer's?

Mesenchymal stem cells (MSCs) are the most commonly used in Alzheimer’s research due to their anti-inflammatory and neuroprotective properties. Induced pluripotent stem cells (iPSCs) and neural stem cells (NSCs) are also studied for their potential to replace lost neurons and model disease mechanisms in the lab.

Is stem cell therapy safe?

Stem cell therapy has shown a good safety profile in early Alzheimer’s trials, with no serious adverse events reported. Stem cell treatments categorized as HCTs are generally safe.

Does stem cell therapy work for brain damage?

Stem cell therapy shows promise in treating brain damage by promoting repair, reducing inflammation, and supporting neuron survival. Early studies in stroke, trauma, and neurodegenerative diseases suggest potential benefits, but more research is needed to confirm long-term safety and effectiveness, especially in complex conditions like Alzheimer’s.

Can stem cells reverse memory loss?

Stem cells may help slow or partially reverse memory loss by repairing damaged neurons and reducing brain inflammation. However, current evidence is limited to early-stage trials and animal studies. There is no confirmed clinical proof yet that stem cell therapy can fully reverse memory loss in Alzheimer’s patients.

How much does stem cell therapy cost for Alzheimer's?

Stem cell therapy for Alzheimer’s is still experimental and not covered by insurance. Costs vary widely depending on the provider, treatment protocol, and country. On average, prices range from $4,500 to $33,000 per treatment. These costs may include consultations, diagnostics, stem cell processing, and multiple infusion sessions.

Is Alzheimer's a Genetic (Hereditary) disease?

Genetic factors are known to play a role in Alzheimer's disease. 30% of the patients have dementia in their families. This factor is more effective in patients diagnosed at a younger age (under 65 years old).

Are there any precautions to avoid Alzheimer's disease?

It is known that doing sports is important to avoid Alzheimer's. It is believed that doing physical exercise three times a week reduces the chance of dementia by 70%. Not smoking, consuming vitamin B12, taking vitamin D, reducing alcohol consumption and brain exercises are some of the measures that can be taken against Alzheimer's.

How is Alzheimer's diagnosed?

The most important symptom of Alzheimer's disease is the patient's forgetfulness. However, it is not right to consider all forgetfulness as Alzheimer's. Many people experience forgetfulness in their daily lives, but continue to live without Alzheimer's.
Patients considered to have Alzheimer's disease should be evaluated with neurological examinations, laboratory tests and neuropsychological tests. To people at high risk, EEG, i.e. cortical mapping, MRI and PET scans may also be recommended.

Further Reading Scientific Studies:

More Info

;
All Rights Reserved. ©2018 GenCellPro